#biotechnology
Related Stories (16)
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
August 19, 2026Moderna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026US FDA approves Replimune's skin cancer drug after prior rejections - Reuters
US FDA approves Replimune's skin cancer drug after prior rejections Reuters
August 6, 2026Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition Reuters
August 6, 2026US FDA approves first mRNA flu shot from Moderna - Reuters
US FDA approves first mRNA flu shot from Moderna Reuters
August 6, 2026Tempus to buy cancer test maker Personalis for $1.5 billion - Reuters
Tempus to buy cancer test maker Personalis for $1.5 billion Reuters
July 20, 2026Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal - Reuters
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal Reuters
July 16, 2026Vertex to buy Crinetics for $10 billion in rare-diseases push - Reuters
Vertex to buy Crinetics for $10 billion in rare-diseases push Reuters
July 6, 2026Abivax nears $11 billion valuation after fundraising eases M&A pressure - Reuters
Abivax nears $11 billion valuation after fundraising eases M&A pressure Reuters
July 1, 2026Amgen owes $20.2 million in antibody patent lawsuit, US jury says - Reuters
Amgen owes $20.2 million in antibody patent lawsuit, US jury says Reuters
June 12, 2026China's WuXi sues US over allegations it supports Beijing's military - Reuters
China's WuXi sues US over allegations it supports Beijing's military Reuters
June 11, 2026Focus: Cancer vaccines based on mRNA advance, despite US cuts - Reuters
Focus: Cancer vaccines based on mRNA advance, despite US cuts Reuters
June 9, 2026Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters
March 25, 2026Henrietta Lacks: Family of woman whose cells were 'stolen' settles second lawsuit
Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.
February 28, 2026Related Pages (14)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Amgen owes $20.2 million in antibody patent lawsuit, US jury says
(()=>{"use strict";window.initData=window.initData||{},window.initData.block_widgetbar=function(i,t,a,n,e){function w(a){const w={resizerBridge:t.allocate({areaName:"right"}),affectsLayout:()=>!0,adap
China’s WuXi sues US over allegations it supports Beijing’s military
By Nikita Maria Jino, Kumar Tanishk and Jonathan Stempel June 11 (Reuters) – A Chinese biotechnology company sued the U.S. government on Thursday over being placed on a list of businesses from China
China’s WuXi sues US over allegations it supports Beijing’s military
By Nikita Maria Jino, Kumar Tanishk and Jonathan Stempel June 11 (Reuters) – A Chinese biotechnology company sued the U.S. government on Thursday over being placed on a list of businesses from China
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Merck ultima un acuerdo de 6.000 millones de dólares para comprar la biotecnológica estadounidense Terns Pharma
Las negociaciones se encuentran en una fase avanzada, según informó el ‘Financial Times’ La farmacéutica Merck & Co está cerca de cerrar un acuerdo de aproximadamente 6.000 millones de dólares para a
Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and
Novartis settles with woman's estate over use of her "stolen" cells to advance medicine
February 27, 2026 / 5:34 AM EST / AP Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were take